Supply Chain Ecosystem Analysis now part of DBMR Reports
Market Size in USD Billion
| 2023 –2030 | |
|
|
USD 600.00 million |
| USD 1,711.55 million | |
| % | |
North America Viral Vector Purification Market, By Product and Services (Products and Services), Type (Retroviral Vectors, Vaccine Virus, Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentivirus and Other), Workflow (Upstream Processing and Downstream Processing), Purification Technique (Density-Gradient Ultracentrifugation, Ultrafiltration, Precipitation, Two-Phase Extraction Systems, and Chromatography), Scale of Operation (Preclinical / Clinical and Commercial), Delivery Method (In Vivo and Ex Vivo), Disease Indication (Cancer, Genetic Disorders, Infectious Diseases, Veterinary Disease and Other), Application (Antisense and RNAi, Gene Therapy, Cell Therapy, and Vaccinology), End User (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Contract Development and Manufacturing Organization (CDMO) and Academic/ Research Institutes) – Industry Trends and Forecast to 2030.
The increase in genetic abnormalities and infectious diseases is influencing viral vector generation. For instance, per the Joint United Nations Programme on HIV/AIDS (UNAIDS) Statistics, at the end of 2020, 27.5 million people in this region were living with HIV, and 1.5 million individuals became newly infected with HIV. Around 87% of those living with HIV were aware of their HIV status and were receiving antiretroviral therapy, with 90% of those on the treatment being virally repressed.
Data Bridge Market Research analyses that the viral vector purification market, which was USD 600 million in 2022, would rise to USD 1711.55 billion by 2030 and is expected to undergo a CAGR of 14% from 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product and Services (Products and Services), Type (Retroviral Vectors, Vaccine Virus, Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentivirus, and Others), Workflow (Upstream Processing and Downstream Processing), Purification Technique (Density-Gradient Ultracentrifugation, Ultrafiltration, Precipitation, Two-Phase Extraction Systems, and Chromatography), Scale of Operation (Preclinical / Clinical and Commercial), Delivery Method (In Vivo and Ex Vivo), Disease Indication (Cancer, Genetic Disorders, Infectious Diseases, Veterinary Disease and Other), Application (Antisense and RNAi, Gene Therapy, Cell Therapy, and Vaccinology), End User (Biotechnology Companies, Pharmaceutical Companies, Contract Research Organizations, Contract Development and Manufacturing Organization (CDMO) and Academic/ Research Institutes)
|
|
Countries Covered
|
U.S., Canada, and Mexico in North America
|
|
Market Players Covered
|
Applied Biological Materials Inc. (Canada), Creative Biolabs (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Sirion-Biotech GmbH (Germany), Merck KGaA (Germany), Batavia Biosciences B.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Addgene (U.S.), IDT Biologika GmbH (Germany), ProBioGen AG (Germany), Takara Bio Inc. (Japan), Thermo Fisher Scientific Inc. (U.S.), Waisman Biomanufacturing (U.S.), Creative Biogene (U.S.), Aldevron (U.S.), uniQure N.V. (Netherlands), BioVision Inc. (U.S.), Cytiva (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Viral vectors are used to deliver genetic material into cells. This process can be carried out in vivo or cell culture (in vitro). Viruses have been developed by particular molecular mechanisms to transport their genomes successfully inside the cells they infect. Chromatography is the most used method for the large-scale purification of vaccines and viral gene therapy vectors.
Drivers
The increasing research activities by different organizations lead to market growth. As per the U.S. FDA estimates, approval of 10 to 20 gene and cell therapy products is expected each year. This states that major market entities are expanding pipeline and R&D programs for advanced therapy products. Therapy developers and researchers expect this to increase the demand for viral vectors. Thus, this factor increases the market growth.
The development of various innovative therapies, such as gene therapy, which uses numerous viral and non-viral vectors to treat various heritable and acquired diseases, has paved the way for treating infectious diseases. This, in turn, will act as an important market growth determinant. Growing expenditure by public and private market players on developing healthcare infrastructure will also enhance market growth. Persistent research and development leading to advanced healthcare technologies will increase the scope of growth. Thus, this factor boosts market growth.
Opportunities
There have been major public and private sector initiatives that are being taken for the development of viral vector vaccines. There are several key players to invest in capacity expansion for manufacturing activities. For instance, Thermo Fisher opened a new manufacturing facility for viral vector production in Plainville, Massachusetts, in 2022. The 300,000-square-foot plant was launched to develop viral vectors, which are essential components in the development of gene therapies. Thus, this factor boosts market growth.
Restraints/Challenges
The huge cost of gene therapies and PCR technologies required to purify vectors impedes the market growth. The machines also need regular maintenance, which causes high costs as well. Thus, these factors hamper the market growth.
This viral vector purification market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the viral vector purification market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
The viral vector purification market is segmented on the basis of type, workflow, purification technique, type, scale of operation, delivery method, disease indication, application, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
Workflow
Purification Technique
Scale of Operation
Delivery Method
Disease Indication
Application
End User
The viral vector purification market is analyzed and market size insights and trends are provided by type, workflow, purification technique, type, scale of operation, delivery method, disease indication, application, and end user as referenced above.
The countries covered in the viral vector purification market report are U.S., Canada, and Mexico in North America
The U.S. dominates the viral vector purification market due to patients' increasing adoption of viral vector purification in the region. Also, the market is increasing the growth in the North American market because of the enormous presence of major market players in the region. The increasing advancement in viral vector purification’ industry is also boosting the market growth in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of north america brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The viral vector purification market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for viral vector purification market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the viral vector purification market. The data is available for historic period 2011-2021.
The viral vector purification market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, north america presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to viral vector purification market.
Some of the major players operating in the viral vector purification market are:
SKU-
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.